THL Partners Acquires Majority Stake in Red Nucleus from The Riverside Company

October 17, 2024

THL Partners (Thomas H. Lee Partners) has made a majority investment in Red Nucleus, a Yardley, Pennsylvania-based provider of medical communications, market access, learning & development, and R&D support for the life sciences industry. The Riverside Company sold its investment in Red Nucleus; the deal closed October 17, 2024 and will support expansion of Red Nucleus’ commercialization services under new CEO Mike Menta and continued involvement from founder Ian Kelly.

Buyers
THL Partners (Thomas H. Lee Partners)
Targets
Red Nucleus
Sellers
The Riverside Company (Riverside), Riverside Capital Appreciation strategy (RCAF)
Location
Pennsylvania, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.